Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-829-7 | CAS number: 922165-31-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 04 - November 07, 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 1,4-bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate
- EC Number:
- 618-829-7
- Cas Number:
- 922165-31-9
- Molecular formula:
- C20H36O8
- IUPAC Name:
- 1,4-bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate
- Details on test material:
- - Name of test material (as cited in study report): CH-CA
- Appearance: Colorless liquid
- Storage condition of test material: Room temperature in airtight container
- Stability under storage conditions: Unknown
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Producer: Jung-Ang Lab. Animal Co., Ltd., Seoul, Korea
- Age at study initiation: 5 weeks
- Weight at study initiation: 304-402 g
- Housing: Animals were individually housed in labeled stainless steel wire cages (height 18 cm).
- Diet (e.g. ad libitum): Free access to Purina experimental diet for guinea-pig 5065 (Lot no. KSN:08:01:LNS, KSN:08:22:CMS, KSN:09:15:CMS from Agribrandts Purina Korwa, Inc.).
- Water (e.g. ad libitum): Free access to tap water.
- Acclimation period: The acclimatization period was 12 days before the start of treatment under laboratory conditions.
- Health inspection: Upon receipt of animals, all animals were given veterinary quarantine. During the acclimation period, animals were observed for clinical signs once a day.
The diet was analyzed periodically by the manufacturer. Upon receipt of the certificate from the manufacturer, the contaminants in the diet were checked twice a year in Korea Testing and Research Institute for Chemical Industry. These results of all analytical items were confirmed within the range of the contaminant limit set in Biotoxtech Co., Ltd.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.4 – 23.1ºC
- Humidity (%): 43.9 - 63.1%
- Washing and sterilization of cages, fodder tub, water bottles and animal room:
Cages, fodder tub and water bottles: MICRO QUAT (400 fold, component: Alkyldimethylbenzyl ammonium chloride, ECOLAB, Inc. Korea) solution was used to wash cages, fodder tub and water bottles. A cage, fodder tub and water bottle were replaced once a week.
Disinfections of the animal room: After the daily work, Pacom - A (component: Octyldecyl dimethyl ammonium chloride, 200 fold, SAMU MEDIAN Co., Ltd., Kora), MICRO-QUAT (component: Alkyldimethyl-benzyl ammonium chloride, 400 fold, ECOLAB Co., Ltd., Korea) and BROMO-SEPT (component : Di-decyl di-methyl ammonium bromide, 300 fold, DAE SUNG MICROBIOLOGICAL LABS. Co., Ltd., Korea) solutions were used to disinfect the animals room. Three antiseptic solutions were replaced every 10 days (respectively).
- Air changes (per hr): 10-15 air changes per hour (all fresh air method)
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours darkness per day. Intensity of illumination 150-300 Lux.
IN-LIFE DATES: From: September 19 to October 10, 2006
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: 1,3-butylene glycol (1,3-BG)
- Concentration / amount:
- 50% test substance for the intradermal induction.
100% test substance for the epicutaneous induction and the challenge exposure.
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: 1,3-butylene glycol (1,3-BG)
- Concentration / amount:
- 50% test substance for the intradermal induction.
100% test substance for the epicutaneous induction and the challenge exposure.
- No. of animals per dose:
- Test substance group 10 animals, vehicle group 5 animals.
- Details on study design:
- RANGE FINDING TESTS:
Concentrations: 100, 50, 25, 12.5, 6.25 and 3.13% (v/v) with 1,3-BG were used for intradermal and topical application.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: one intradermal (day 0) and one topical (day 7, 48h).
- Exposure period: 24 h topical induction. SDS was applied to the application site.
B. CHALLENGE EXPOSURE
- No. of exposures: 1 topical
- Day(s) of challenge: 2 weeks after last induction.
- Exposure period: 24 hours.
- Site: The left and right flanks
- Evaluation (hr after challenge): 24 and 48 hours - Positive control substance(s):
- yes
- Remarks:
- every 6 months 1-chloro-2,4-dinitrobenzene
Study design: in vivo (LLNA)
- Statistics:
- Scores and raw data such as body weights were not statistically analyzed, but mean values were calculated
Results and discussion
- Positive control results:
- The six-month reliability check with CDNB (1 -Chloro-2,4 -Dinitrobenzene) indicates that the Maximization test as performed at BIotoxtech is an appropriate model for testing for contact hypersensitivity. See the document 'Reliability check' in the attached background material.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- First induction: 50% test substance, second induction: 100% test substance; Challenge: 100% test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- There were no detectable clinical signs in all animals in relation to the test substance.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: First induction: 50% test substance, second induction: 100% test substance; Challenge: 100% test substance. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: There were no detectable clinical signs in all animals in relation to the test substance. .
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100% 1,3-BG
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- There were no detectable clinical signs in all animals. All animals survived to the scheduled observation period.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 100% 1,3-BG. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: There were no detectable clinical signs in all animals. All animals survived to the scheduled observation period..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- First induction: 50% test substance, second induction: 100% test substance; Challenge: 100% test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- There were no detectable clinical signs in all animals in relation to the test substance. All animals survived to the scheduled observation period.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: First induction: 50% test substance, second induction: 100% test substance; Challenge: 100% test substance. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: There were no detectable clinical signs in all animals in relation to the test substance. All animals survived to the scheduled observation period..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100% 1,3-BG
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- There were no detectable clinical signs in all animals. All animals survived to the scheduled observation period.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 100% 1,3-BG. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: There were no detectable clinical signs in all animals. All animals survived to the scheduled observation period..
Any other information on results incl. tables
Tables of the Main study have been included in the document "Sensitization tables" in the attached background material.
Results Pre-screen test:
Intradermal: in 24 and 48 hours after treatment, each evaluated concentrations showed following skin reactions as intense redness and necrosis (score 3) in 2/2 guinea pigs at 100% concentration; moderate redness (score 2) in 2/2 guinea pigs at 50 and 25% concentrations; moderate (score 2) and mild redness (score 1) in 1/2 guinea pig each at 12.5% concentration; mild redness at 6.25% and 3.13%. Thus, 50% was used (highest to cause irritation but not adversely affecting the animals).
Topical: at 24 and 48 hours after the patch removal, there were no skin reactions.
In addition, the highest concentration for the topical induction and challenge were decided as 100% since there was no skin reaction after the patch removal for all concentrations.
Other results - main study:
There were no detectable clinical signs in all animals. All animals survived to the scheduled observation period.
The body weights were normally increased in all test groups during the observation period (the averages of increased body weights were 182 g and 175 g in test substance group and vehicle group, respectively).
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- In a guinea pig maximization test performed according to OECD 406 and GLP, CH-CA showed no skin sensitising properties in guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.